The financing round was led by French mutual insurance companies, with the support of Cureety’s existing investors, bank pool and... View Article
Author Archives for Adeline Chauvigné
CUREETY, the French start-up specialized in data and remote-monitoring in oncology, raises €5 million
5 August 2025The financing round was led by French mutual insurance companies, with the support of Cureety’s existing investors, bank pool and... View Article
New member | GenSensor
By 2024, forecasts indicate that 50% of the top 100 most prescribed drugs will be biologics, accounting for 32% of... View Article
New member | GenSensor
5 August 2025By 2024, forecasts indicate that 50% of the top 100 most prescribed drugs will be biologics, accounting for 32% of... View Article
Valneva advances booster phase of Cov-Compare trial of its inactivated COVID-19 vaccine candidate
Valneva, a specialty vaccine company, today announced the start of booster vaccinations in adult participants from its Phase 3 pivotal... View Article
Valneva advances booster phase of Cov-Compare trial of its inactivated COVID-19 vaccine candidate
5 August 2025Valneva, a specialty vaccine company, today announced the start of booster vaccinations in adult participants from its Phase 3 pivotal... View Article
OSE Immunotherapeutics receives first notice of allowance of a patent for use of Tedopi®
OSE Immunotherapeutics receives first notice of allowance of a patent for use of Tedopi® after failure with PD-1 or PD-L1... View Article
OSE Immunotherapeutics receives first notice of allowance of a patent for use of Tedopi®
5 August 2025OSE Immunotherapeutics receives first notice of allowance of a patent for use of Tedopi® after failure with PD-1 or PD-L1... View Article
Valneva’s inactivated COVID-19 vaccine candidate shown to neutralize Omicron Variant
Preliminary laboratory studies demonstrate that three doses of Valneva’s inactivated COVID-19 vaccine candidate VLA2001 induced neutralization of the Omicron variant.... View Article
Valneva’s inactivated COVID-19 vaccine candidate shown to neutralize Omicron Variant
5 August 2025Preliminary laboratory studies demonstrate that three doses of Valneva’s inactivated COVID-19 vaccine candidate VLA2001 induced neutralization of the Omicron variant.... View Article
New member | PhosphoTech
PhosphoTech Laboratories is an international player specialising in the production of high added value marine ingredients. The company is based... View Article
New member | PhosphoTech
5 August 2025PhosphoTech Laboratories is an international player specialising in the production of high added value marine ingredients. The company is based... View Article
New member | Stimul’in
The mission of Stimul’in is to enhance the daily life of people with neurocognitive troubles, their families and their health... View Article
New member | Stimul’in
5 August 2025The mission of Stimul’in is to enhance the daily life of people with neurocognitive troubles, their families and their health... View Article
InFlectis BioScience receives approval from the French regulatory authority to conduct a phase 2 clinical trial for IFB-088 (Icerguastat) for the treatment of Amyotrophic Lateral Sclerosis
InFlectis BioScience, a clinical-stage company developing innovative therapeutics for neuromuscular diseases by harnessing the Integrated Stress Response (ISR), receives approval from the... View Article
InFlectis BioScience receives approval from the French regulatory authority to conduct a phase 2 clinical trial for IFB-088 (Icerguastat) for the treatment of Amyotrophic Lateral Sclerosis
5 August 2025InFlectis BioScience, a clinical-stage company developing innovative therapeutics for neuromuscular diseases by harnessing the Integrated Stress Response (ISR), receives approval from the... View Article
Valneva confirms clinical trial and regulatory submission timelines for its inactivated COVID-19 vaccine candidate VLA2001
Valneva, a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials and regulatory submissions for its... View Article
Valneva confirms clinical trial and regulatory submission timelines for its inactivated COVID-19 vaccine candidate VLA2001
5 August 2025Valneva, a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials and regulatory submissions for its... View Article
New member | Exportis
Exportis, based in Angers, is a marketing and sales services platform for startups and SMEs in the health sector, wishing... View Article
New member | Exportis
5 August 2025Exportis, based in Angers, is a marketing and sales services platform for startups and SMEs in the health sector, wishing... View Article